Pre-Market Surge For Precision BioSciences (DTIL) On Groundbreaking Trial Data
Fahim Awan
January 10, 2025
After a landmark clinical trial revealed a full clinical response in the first infant dosage, Precision BioSciences, Inc. (NASDAQ: DTIL) shares are rocketing this morning.